Cargando…

Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials

Background: Ascorbate (vitamin C) has been evaluated as a potential treatment for cancer as an independent agent and in combination with standard chemotherapies. This review assesses the evidence for safety and clinical effectiveness of intravenous (IV) ascorbate in treating various types of cancer....

Descripción completa

Detalles Bibliográficos
Autores principales:	Nauman, Gina, Gray, Javaughn Corey, Parkinson, Rose, Levine, Mark, Paller, Channing J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071214/ https://www.ncbi.nlm.nih.gov/pubmed/30002308 http://dx.doi.org/10.3390/antiox7070089

Ejemplares similares

Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer
por: Bazzan, Anthony J., et al.
Publicado: (2018)

A Review of Pomegranate in Prostate Cancer
por: Paller, Channing J., et al.
Publicado: (2017)

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer
por: Gordon, Nicolas, et al.
Publicado: (2023)

Modulation of Cytokines in Cancer Patients by Intravenous Ascorbate Therapy
por: Mikirova, Nina, et al.
Publicado: (2016)

Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
por: Monti, Daniel A., et al.
Publicado: (2012)

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
por: Ichim, Thomas E, et al.
Publicado: (2011)

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
por: Paller, Channing J, et al.
Publicado: (2011)

Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer
por: Paller, Channing J., et al.
Publicado: (2023)

Applications for open access normalized synthesis in metastatic prostate cancer trials
por: Luechtefeld, Thomas, et al.
Publicado: (2022)

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
por: Fowler, Alpha A, et al.
Publicado: (2014)

Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Review
por: Idossa, Dame, et al.
Publicado: (2022)

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
por: Wagner, Samuel C, et al.
Publicado: (2014)

Administration of Intravenous Ascorbic Acid—Practical Considerations for Clinicians
por: Walker, Scott E., et al.
Publicado: (2019)

(177)Lu-PSMA Radioligand Therapy Is Favorable as Third-Line Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: von Eyben, Finn E., et al.
Publicado: (2021)

Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
por: Stephenson, Christopher M., et al.
Publicado: (2013)

Comparative Study of Intravenous Iron Versus Intravenous Ascorbic Acid for Treatment of Functional Iron Deficiency in Patients Under Hemodialysis: A Randomized Clinical Trial
por: Sedighi, Omid, et al.
Publicado: (2013)

Pharmacologic Ascorbate in Myeloma Treatment: Doses Matter
por: Violet, Pierre-Christian, et al.
Publicado: (2017)

The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
por: Kang, Dae Woong, et al.
Publicado: (2012)

Role of Intravenous Ascorbic Acid in the Management of Anemia in Hemodialysis Patients
por: El Shinnawy, Howayda, et al.
Publicado: (2021)

Stability of aqueous solutions of ascorbate for basic research and for intravenous administration
por: Wagner, Brett A., et al.
Publicado: (2023)

Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller, Channing J, et al.
Publicado: (2012)

PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
por: Jones, Wallace, et al.
Publicado: (2020)

A Case of Factitious Hyperglycemia in a Patient on Intravenous Ascorbic Acid
por: Sharma, Eliza, et al.
Publicado: (2018)

Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer
por: Jang, Albert, et al.
Publicado: (2020)

Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients
por: Mikirova, Nina, et al.
Publicado: (2013)

Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial
por: Coppock, Dagan, et al.
Publicado: (2022)

Effect of short-term intravenous ascorbic acid on reducing ferritin in hemodialysis patients
por: Jalalzadeh, M., et al.
Publicado: (2012)

Intravenous Ascorbic Acid and Lung Function in Severely Ill COVID-19 Patients
por: Sokary, Sara, et al.
Publicado: (2022)

Vitamin C Administration by Intravenous Infusion Increases Tumor Ascorbate Content in Patients With Colon Cancer: A Clinical Intervention Study
por: Dachs, Gabi U., et al.
Publicado: (2021)

A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer
por: Palma dos Reis, Ana Filipa, et al.
Publicado: (2022)

Editorial: Big Data and machine learning in cancer theranostics
por: da Silva, Fabricio Alves Barbosa, et al.
Publicado: (2022)

The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review
por: van Gorkom, Gwendolyn N.Y., et al.
Publicado: (2019)

Membrane Permeabilities of Ascorbic Acid and Ascorbate
por: Hannesschlaeger, Christof, et al.
Publicado: (2018)

The human sodium-dependent ascorbic acid transporters SLC23A1 and SLC23A2 do not mediate ascorbic acid release in the proximal renal epithelial cell
por: Eck, Peter, et al.
Publicado: (2013)

Pharmacokinetics of intravenous administered two different high doses of ascorbic acid in healthy beagle dogs
por: Lim, Seula, et al.
Publicado: (2019)

Measuring Cancer Hallmark Mediation of the TET1 Glioma Survival Effect with Linked Neural-Network Based Mediation Experiments
por: Luechtefeld, Thomas, et al.
Publicado: (2020)

Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications
por: El Halabi, Ibrahim, et al.
Publicado: (2018)

Functionally Enigmatic Genes in Cancer: Using TCGA Data to Map the Limitations of Annotations
por: Maertens, Alexandra, et al.
Publicado: (2020)

Author Correction: Functionally Enigmatic Genes in Cancer: Using TCGA Data to Map the Limitations of Annotations
por: Maertens, Alexandra, et al.
Publicado: (2020)

High-Dose Intravenous Ascorbate in Sepsis, a Pro-Oxidant Enhanced Microbicidal Activity and the Effect on Neutrophil Functions
por: Sae-khow, Kritsanawan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dgic9b446q82i17natqe425g54